コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 leased by the skin affected by AD (including thymic stromal lymphopoietin).
2 al keratinocytes increased the production of thymic stromal lymphopoietin.
3 moderate affinity for IL-7 but does not bind thymic stromal lymphopoietin.
4 prostaglandin E(2), interleukin (IL)-10, and thymic stromal lymphopoietin.
5 feron gamma, tumor necrosis factor alpha, or thymic stromal lymphopoietin.
6 production by activating dendritic cells via thymic stromal lymphopoietin.
7 , IL-1alpha, IL-1beta, CCL20/MIP-3alpha, and thymic stromal lymphopoietin.
8 BLIN-4L could also respond to human thymic stromal lymphopoietin.
9 inflammatory markers IL-1, IL-4, IL-13, and thymic stromal lymphopoietin.
10 the interplay with dendritic cells primed by thymic stromal lymphopoietin.
13 als expressed significantly higher levels of thymic stromal lymphopoietin, a major proinflammatory cy
17 e resulting class switching was amplified by thymic stromal lymphopoietin, an epithelial interleukin
18 in(-)CD45R(lo-neg)CD19(+) cells responded to thymic stromal lymphopoietin and 'preferentially' recons
19 ry cytokines and chemokines, including IL-5, thymic stromal lymphopoietin and CCL11, that help to ini
21 on house dust mite (HDM)-induced release of thymic stromal lymphopoietin and GM-CSF from tracheal ep
26 the receptor for the Th2-promoting cytokine thymic stromal lymphopoietin and the high-affinity IgE r
27 cteristics of receptors for IL-4, IL-13, and thymic stromal lymphopoietin and their respective ligand
28 ion of ATP receptor P2X7R, and production of thymic stromal lymphopoietin and type 1, type 2, and typ
29 L-18 receptor 1 (IL1RL1-IL18R1), RAD50-IL13, thymic stromal lymphopoietin and WD repeat domain 36 reg
30 )2-stimulating epithelial factors (IL-33 and thymic stromal lymphopoietin) and T(H)2 cytokines (IL-4,
31 f CCL20/macrophage-inducible protein 3alpha, thymic stromal lymphopoietin, and CCL3-like 1 because of
33 lease cytokines, such as IL-1, IL-25, IL-33, thymic stromal lymphopoietin, and GM-CSF, and endogenous
34 hology, including IL-4, IL-13, IL-22, IL-31, thymic stromal lymphopoietin, and IFN-gamma, signal thro
35 and a reduction in AD-related cytokine IL-8, thymic stromal lymphopoietin, and IL-10 secretion were o
36 ounding, migratory epithelia produce CXCL10, thymic stromal lymphopoietin, and IL-1beta and its antag
39 cytokine responses such as IL-25, IL-33, and thymic stromal lymphopoietin, and increasing the epithel
40 Their persistence in skin required IL-7 and thymic stromal lymphopoietin, and localization was depen
41 increased expression of IL-4, IL-13, IL-22, thymic stromal lymphopoietin, and other cytokines associ
42 were those noted in TH2 (IL13, CCL18, CCL26, thymic stromal lymphopoietin, and periostin), TH9/IL-9,
43 the proallergic cytokines IL-1alpha, IL-33, thymic stromal lymphopoietin, and the growth factor amph
44 n of chemokine and cytokine genes, including thymic stromal lymphopoietin; and skin remodeling with f
45 g antibodies against IL-5, IL-13, IL-33, and thymic stromal lymphopoietin, as well as oral chemoattra
46 serum markers (CCL2, CCL5, CCL11, IL-3, and thymic stromal lymphopoietin) at 3 time points (ie, duri
47 of cytokines (interleukin [IL] 25, IL33, and thymic stromal lymphopoietin) by colon tissues, which ac
48 k the function of relevant molecules such as thymic stromal lymphopoietin, chemoattractant-receptor h
52 epithelial layer, such as IL-25, IL-33, and thymic stromal lymphopoietin, engage and activate each o
53 sinophils, mast cell activation, increase of thymic stromal lymphopoietin, eotaxin-1 and type 2 cytok
55 17 responses, along with increased IL-36 and thymic stromal lymphopoietin expression, which were furt
56 identified genetic perturbations (eotaxin-3, thymic stromal lymphopoietin, IL-13, and filaggrin) that
57 cells preferentially expressed receptors for thymic stromal lymphopoietin, IL-25, and IL-33 and demon
58 outcomes, with an emphasis on the actions of thymic stromal lymphopoietin, IL-25, and IL-33 at the ep
59 d cells (ILC2s); dendritic cells primed with thymic stromal lymphopoietin, IL-25, and IL-33; and B an
60 e, we provide a brief review of the roles of thymic stromal lymphopoietin, IL-33, and IL-25 in divers
61 r biologics similarly inhibit TH2 cytokines (thymic stromal lymphopoietin, IL-4, IL-5, IL-13, and the
62 2-associated cytokines (interleukin (IL)-33, thymic stromal lymphopoietin, IL-5 and IL-13), serum imm
63 y inflammatory mediators from AECs including thymic stromal lymphopoietin, IL-6, and PGE2, in part th
64 MCT feeding stimulated jejunal-epithelial thymic stromal lymphopoietin, Il25, and Il33 expression
65 he non-haematopoietic-cell-derived cytokines thymic stromal lymphopoietin, IL33 and IL25 (also known
66 -CSF and chemokines such as CCL2, CCL20, and thymic stromal lymphopoietin in epithelial cells through
68 n of the epithelial-cell-restricted cytokine thymic stromal lymphopoietin in the intestine and, after
70 ion for the Th2-inducing cytokines IL-33 and thymic stromal lymphopoietin in WT mice with colitis, wh
71 and stimulated secretion of IL-8, IL-10, and thymic stromal lymphopoietin independent of PAR2 activit
73 two-step mechanism has been hypothesized: a thymic stromal lymphopoietin-induced allergic sensitizat
75 1, VCAM-1, E-selectin, RANTES, IL-17, IL-33, thymic stromal lymphopoietin, inducible NO synthase, and
76 nd activation-regulated chemokine, IL-5, and thymic stromal lymphopoietin levels were significantly i
77 ar destruction, which results in lower serum thymic stromal lymphopoietin levels, milder B-cell lymph
78 itic cells (that have been "educated" by the thymic stromal lymphopoietin molecule produced by a thym
79 esponses and airway pathology, and IL-33 and thymic stromal lymphopoietin most likely play key roles
80 nide (iLNP(BUD5)) to deliver mRNA encoding a thymic stromal lymphopoietin nanobody (mnbTSLP) for the
81 ytokines (eg, IL-4, IL-13, IL-31, IL-33, and thymic stromal lymphopoietin), neurotransmitters (eg, su
88 Mice deficient in IL-33R (Il1rl1(-/-)) and thymic stromal lymphopoietin receptor (Tslpr(-/-)) showe
89 ession profiling and to assess the effect of thymic stromal lymphopoietin receptor (TSLPR) blockade i
90 dependently of IL-3 by increasing functional thymic stromal lymphopoietin receptor (TSLPR) expression
95 on expression levels of receptors for TSLP (thymic stromal lymphopoietin receptor [TSLPR] and CD127)
99 rface-activating receptors, such as CD48 and thymic stromal lymphopoietin receptors, as well as inhib
100 f autocrine/paracrine IL-10, IL-4, IL-22 and thymic stromal lymphopoietin regulated these JAK-depende
101 protease-activated receptor 2, resulting in thymic stromal lymphopoietin secretion and a cutaneous T
104 ckout (FcRgamma(-/-)) mice were crossed with thymic stromal lymphopoietin transgenic (TSLPtg) mice, w
105 sin II type 1 receptor blocker (losartan) in thymic stromal lymphopoietin transgenic (TSLPtg) mice, w
106 In addition, administration of imatinib to thymic stromal lymphopoietin transgenic mice with establ
107 tested the protective effects of imatinib in thymic stromal lymphopoietin transgenic mice, a model of
108 P = 0.01), higher mRNA transcript numbers of thymic stromal lymphopoietin (TSLP) (1.6-fold, P = 0.009
109 l roles in allergic inflammation mediated by thymic stromal lymphopoietin (TSLP) (see the related art
110 We evaluated the role of the innate cytokine thymic stromal lymphopoietin (TSLP) acting on mast cells
111 ls that was dependent on the innate cytokine thymic stromal lymphopoietin (TSLP) and also induced ano
112 hat have been epicutaneously sensitized with thymic stromal lymphopoietin (TSLP) and antigen to repea
114 decreased the IL-1beta-mediated increases in thymic stromal lymphopoietin (TSLP) and GM-CSF in primar
116 nses are developed simultaneously, driven by thymic stromal lymphopoietin (TSLP) and IL-23, respectiv
117 irements for the epithelial cytokines IL-33, thymic stromal lymphopoietin (TSLP) and IL-25 in the act
119 thelial cell-derived danger signal mediators thymic stromal lymphopoietin (TSLP) and IL-33 are consis
121 eosinophilia, as well as increased levels of thymic stromal lymphopoietin (TSLP) and IL-5 in the skin
125 in the blood myeloid compartment as well as thymic stromal lymphopoietin (TSLP) and transforming gro
126 licating hepatic epithelial-derived cytokine thymic stromal lymphopoietin (TSLP) and type 2 immunity,
127 cells was suppressed by anti-IL-1 and anti- thymic stromal lymphopoietin (TSLP) and was enhanced by
128 ymorphisms in the gene encoding the cytokine thymic stromal lymphopoietin (TSLP) are associated with
133 that both genetic and chemical induction of thymic stromal lymphopoietin (TSLP) at a distant site le
135 onstrate that the overproduction of cytokine thymic stromal lymphopoietin (TSLP) by AD skin promotes
136 ted that this was the result of secretion of thymic stromal lymphopoietin (TSLP) by cancer cells.
137 dized lipids that triggered the induction of thymic stromal lymphopoietin (TSLP) by epithelial cells
138 mice were associated with overproduction of thymic stromal lymphopoietin (TSLP) by IECs, which negat
140 ial cell-derived cytokines IL-25, IL-33, and thymic stromal lymphopoietin (TSLP) can promote CD4(+) T
145 resembling atopic dermatitis and relying on thymic stromal lymphopoietin (TSLP) from keratinocytes a
146 rotease inhibitor Kazal-type 5 (SPINK5), and thymic stromal lymphopoietin (TSLP) gene variants and ch
161 monstrate a previously unrecognized role for thymic stromal lymphopoietin (TSLP) in promoting the pop
163 the role of the epithelial-derived cytokine thymic stromal lymphopoietin (TSLP) in the response to R
164 Mice overexpressing the proallergic cytokine thymic stromal lymphopoietin (TSLP) in the skin develop
203 romote the growth and activation of B cells, thymic stromal lymphopoietin (TSLP) is now known to have
208 lls and innate immune cells via the cytokine thymic stromal lymphopoietin (TSLP) is thought to drive
209 ic march suggest that systemic, skin-derived thymic stromal lymphopoietin (TSLP) mediates progression
213 owed that dendritic cells (DCs) activated by thymic stromal lymphopoietin (TSLP) prime naive CD4(+) T
214 We previously showed that mDCs, educated by thymic stromal lymphopoietin (TSLP) produced by the epit
215 triggered by an increased expression of the thymic stromal lymphopoietin (TSLP) proinflammatory cyto
221 Recent studies revealed a critical role for thymic stromal lymphopoietin (TSLP) released from epithe
222 se-activated receptor 2 (PAR2), resulting in thymic stromal lymphopoietin (TSLP) secretion and a cuta
225 component of the receptors for both IL-7 and thymic stromal lymphopoietin (TSLP) suggests that IL-2 c
226 genomic databases, and its homology to mouse thymic stromal lymphopoietin (TSLP) suggests that it is
229 nemia in the development of liver disease in thymic stromal lymphopoietin (TSLP) transgenic mice that
230 genital mucosal epithelial cells to produce thymic stromal lymphopoietin (TSLP) via activation of th
231 2 balance by downregulating the secretion of thymic stromal lymphopoietin (TSLP) via inactivation of
233 e tissue-derived cytokines IL-25, IL-33, and thymic stromal lymphopoietin (TSLP) was significantly di
234 not different between the mouse strains, but thymic stromal lymphopoietin (TSLP) was significantly in
235 el cytokine from a thymic stromal cell line (thymic stromal lymphopoietin (TSLP)) promotes the develo
236 so when ILC2s were stimulated with IL-7 and thymic stromal lymphopoietin (TSLP), 2 ligands of IL-7 r
237 s also proposed to control the activation of thymic stromal lymphopoietin (TSLP), a cytokine implicat
239 with polymorphisms in the gene that encodes thymic stromal lymphopoietin (TSLP), a cytokine that pro
244 rus infection or dsRNA stimulation increased thymic stromal lymphopoietin (TSLP), an upstream pro-all
245 in association with induction of Il33, Csf2, thymic stromal lymphopoietin (Tslp), and Ccl20 transcrip
246 several cytokines (e.g., IL-4, IL-12, IL-23, thymic stromal lymphopoietin (TSLP), and IFNgamma) impli
247 40, tumor necrosis factor-alpha (TNF-alpha), Thymic stromal lymphopoietin (TSLP), and macrophage-deri
248 ain innate factors, namely IL-25, IL-33, and thymic stromal lymphopoietin (TSLP), are elaborated by s
249 alarmins, such as interleukin-33 (IL-33) and thymic stromal lymphopoietin (TSLP), are major players i
250 nd mast cells, a higher expression levels of thymic stromal lymphopoietin (TSLP), cathelicidin, prote
251 IL13, C-C motif chemokine ligand 26 (CCL26), thymic stromal lymphopoietin (TSLP), Charcot-Leyden crys
254 s known to activate ILCs (IL-2, IL-7, IL-12, thymic stromal lymphopoietin (TSLP), IL-25, and IL-33).
256 at epithelial cell-derived cytokines such as thymic stromal lymphopoietin (TSLP), IL-33, and IL-25 ma
257 was associated with an increase in levels of thymic stromal lymphopoietin (TSLP), IL-9, and IL-13, bu
258 ative PCR was used to measure mRNA for sHBEC thymic stromal lymphopoietin (TSLP), IL33, POSTN, and IL
259 ht to dissect its role, also in synergy with thymic stromal lymphopoietin (TSLP), in airway inflammat
260 fic for the epithelial-cell-derived cytokine thymic stromal lymphopoietin (TSLP), in patients whose a
262 rtinez-Cingolani et al identified that human thymic stromal lymphopoietin (TSLP), previously shown to
263 ns in receptors for interleukin-7 (IL-7) and thymic stromal lymphopoietin (TSLP), resulting in a nove
264 expression of keratinocyte-derived cytokine, Thymic Stromal Lymphopoietin (TSLP), the key gene in AD
265 ons of the other innate cytokines, IL-33 and thymic stromal lymphopoietin (TSLP), to the observed ast
266 ytokines, interleukin-25 (IL-25), IL-33, and thymic stromal lymphopoietin (TSLP), which nonredundantl
268 Th2 central memory cells are stimulated with thymic stromal lymphopoietin (TSLP)-activated dendritic
269 etween classical IL-3-elicited basophils and thymic stromal lymphopoietin (TSLP)-elicited basophils.
286 re recruited to inflamed skin via CXCL12 and thymic stromal lymphopoietin (TSLP)/IL-3-dependent upreg
287 Intestinal epithelial cells (IECs) produce thymic stromal lymphopoietin (TSLP); however, the in viv
288 ukin-4 (IL-4), IL-5, IL-9, IL-13, IL-31, and thymic stromal lymphopoietin (TSLP); pro-inflammatory cy
289 -6, and soluble IL-6R), epithelial alarmins (thymic stromal lymphopoietin [TSLP] and IL-33), and neut
290 pithelial cell (EC)-derived cytokines (e.g., thymic stromal lymphopoietin [TSLP]) activating human ba
291 Epithelial cytokines (IL-33, IL-25, and thymic stromal lymphopoietin [TSLP]) and mast cell media
292 es usually undetectable on arrays (ie, IL22, thymic stromal lymphopoietin [TSLP], CCL22, and CCL26).
293 B cell progenitors seeded in the presence of thymic stromal lymphopoietin undergo significant expansi
295 helial expression of IL-25, but not IL-33 or thymic stromal lymphopoietin, was increased in a subset
298 In this article, we report that IL-33 and thymic stromal lymphopoietin were produced quickly in th
299 ucing cytokines, including interleukin 4 and thymic stromal lymphopoietin, which are involved in TH2
300 vitro scratch wound initiated the release of thymic stromal lymphopoietin, which was greater in epith